Observations placeholder
Herceptin
Identifier
019104
Type of Spiritual Experience
Number of hallucinations: 62
Background
A description of the experience
Trastuzumab (INN; trade names Herclon, Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers.
On Jan, 04, 2017 18,186 people reported to have side effects when taking Herceptin.
Among them, 62 people (0.34%) have Hallucination
Time on Herceptin when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Herceptin :
| Female | Male | |
| Hallucination | 100.00% | 0.00% |
Age of people who have Hallucination when taking Herceptin :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 54.00% | 34.00% | 2.00% | 10.00% |
On Nov, 30, 2015: 10,362 people reported to have side effects when taking Herceptin. Among them, 388 people (3.74%) have Death.
Time on Herceptin when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 41.03% | 25.64% | 25.64% | 7.69% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Herceptin :
| Female | Male | |
| Death | 91.49% | 8.51% |
Age of people who have Death when taking Herceptin :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 0.40% | 10.32% | 15.08% | 29.76% | 44.44% |